These pale colors were once considered undesirable, but have recently become popular due to intensive marketing.Green quartz is sometimes incorrectly called green amethyst, which is a misnomer and not an appropriate name for the material, as the proper terminology is prasiolite. Other names for green quartz are vermarine or lime citrine. Amethyst frequently shows color zoning, with the most intense color typically found at the crystal terminations. It is the most prized variety of quartz. One of a gem cutter’s tasks is to make a finished product with even color. Sometimes, only a thin layer of a natural, uncut amethyst is violet colored, or the color is very uneven. The uncut gem may have only a small portion that is suitable for faceting.The color of amethyst has been demonstrated to result from substitution by irradiation of trivalent iron (Fe3+) for silicon in the structure, in the presence of trace elements of large ionic radius, and to a certain extent, the amethyst color can naturally result from displacement of transition elements even if the iron concentration is low. Natural amethyst is dichroic in reddish violet and bluish violet, but when heated, turns yellow-orange, yellow-brown, or dark brownish and may resemble citrine, but loses its dichroism, unlike genuine citrine. When partially heated, amethyst can result in ametrine. Amethyst can fade in tone if overexposed to light sources and can be artificially darkened with adequate irradiation. It does not fluoresce under either short-wave or long-wave UV light. Geographic distribution
Amethyst is found in many locations around the world.
Care must, therefore, be taken when coming off the medication, usually by a gradual process of tapering down the dose over a period of time. Suicide
Antidepressants may increase the risk of suicidal thoughts and behaviors in children and young adults. Close monitoring for emergence of suicidal thoughts and behaviors is thus recommended. Sedation
Since trazodone may impair the mental and/or physical abilities required for performance of potentially hazardous tasks, such as operating an automobile or machinery, the patient should be cautioned not to engage in such activities while impaired. Compared to the reversible MAOI antidepressant drug moclobemide, more impairment of vigilance occurs with trazodone. Trazodone has been found to impair driving ability. Cardiac
Case reports have noted cardiac arrhythmias emerging in relation to trazodone treatment, both in patients with pre-existing mitral valve prolapse and in patients with negative personal and family histories of cardiac disease.QT prolongation has been reported with trazodone therapy. Arrhythmia identified include isolated PVCs, ventricular couplets, and in two patients short episodes (three to four beats) of ventricular tachycardia. Several post-marketing reports have been made of arrhythmia in trazodone-treated patients who have pre-existing cardiac disease and in some patients who did not have pre-existing cardiac disease. Until the results of prospective studies are available, patients with pre-existing cardiac disease should be closely monitored, particularly for cardiac arrhythmias. Trazodone is not recommended for use during the initial recovery phase of myocardial infarction. Concomitant administration of drugs that prolong the QT interval or that are inhibitors of CYP3A4 may increase the risk of cardiac arrhythmia.